Francisco X. REAL

Centro Nacional de Investigaciones Oncológicas Madrid, Spain

Francisco X. Real (Paco) obtained his M.D. from the Universitat Autònoma de Barcelona in 1980 and his Ph.D. in 1986. He trained in Medical Oncology at Memorial Hospital in New York where he was a Staff Physician from 1986-188.

He carried out his doctoral and postdoctoral work in the laboratory of Lloyd J. Old at Memorial Sloan-Kettering Cancer Center. His work focused on the development of immunological strategies for the treatment of melanoma and epithelial cancers. In 1988 he joined the Institut Municipal d'Investigació Mèdica, Barcelona, where he focused on the cell and molecular biology of epithelial cancers. He was involved in setting up the Biomedical Sciences studies at Universitat Pompeu Fabra, Barcelona, where he is Professor of Cell Biology since 2004. In 2007, he joined the Spanish National Cancer Research Center (CNIO), Madrid. His group has made significant contributions on the molecular mechanisms involved in pancreatic cancer and in pancreatitis and the molecular pathology and epidemiology of bladder and pancreas cancer. His work combines the use of patient samples, cultured cells, and genetically modified mice, giving a similar relevance to all of them. One important aim of the group’s work is to bring the fundamental knowledge generated in the laboratory to an improved understanding of disease and to develop improved strategies for prevention, early diagnosis and treatment of pancreatic and bladder cancer. He has published more than 250 original papers and his work has been published in Nature, Nature Genetics, Nature Cell Biology, Nature Communications, Nature Reviews Cancer, Gut, Gastroenterology, PNAS, JNCI, J Clin Invest, among others. He has received more than 22,000 citations (Google Scholar); his H index is 84. He is member of the Scientific Advisory Board of several institutions including the Science Committee of Cancer Research UK (London), Centre de Recherche des Cordeliers (Paris), CARPEM (Paris), Pancreatic Cancer Research UK (London), and Fonds National de la Recherche Scientifique (Brussels). He is Academic Editor for PLOS ONE and is Associate Editor of Bladder Cancer and Gut. In 2015, he was President of the European Pancreatic Club.